Business ❯ Finance ❯ Market Analysis ❯ Company Performance

Stock Valuation

Boxer Capital Buys 1.24 Million Vir Biotechnology Shares

The buy underscores improving sentiment, with promising trial data plus a pending Astellas payment bolstering the case.

Pfizer Posts Higher Q1 Sales but Lower Profit, Raising Fresh Questions About Its Dividend

Kraft Heinz Faces Investor Push to Spin Off Faster-Growing Global Brands

Market Reprices AI Leaders as Nvidia’s Forward P/E Hits Seven-Year Low

ARK Invest Sells $84 Million in Tech and Chip Stocks, Adds Tempus AI

Beaconlight Slashes Advance Auto Parts Stake With $6.2 Million Q4 Sale

ARK Cuts Tesla Stake and Scoops Up Broadcom in January Tech Rotation

Oklo Shares Rebound After Three-Day Selloff as Scrutiny of Valuation and Reactor Design Grows

Warren Buffett's Berkshire Hathaway Sells Record $132 Billion in Stocks